Your browser doesn't support javascript.
loading
Design of Dense Brush Conformation Bearing Gold Nanoparticles as Theranostic Agent for Cancer.
Verimli, Nihan; Demiral, Aysegül; Yilmaz, Hülya; Çulha, Mustafa; Erdem, S Sibel.
Afiliação
  • Verimli N; International School of Medicine, Medical Biochemistry, Istanbul Medipol University, 34810, Istanbul, Turkey.
  • Demiral A; Regenerative and Restorative Medical Research Center (REMER), 34810, Istanbul, Turkey.
  • Yilmaz H; Regenerative and Restorative Medical Research Center (REMER), 34810, Istanbul, Turkey.
  • Çulha M; School of Engineering and Natural Sciences, Biomedical Engineering, Istanbul Medipol University, 34810, Istanbul, Turkey.
  • Erdem SS; Faculty of Engineering, Department of Genetics and Bioengineering, Yeditepe University, 34755, Istanbul, Turkey.
Appl Biochem Biotechnol ; 189(3): 709-728, 2019 Nov.
Article em En | MEDLINE | ID: mdl-31602558
ABSTRACT
Dense brush conformation-bearing theranostic agents are emerging as drug delivery systems due to their higher ability to escape from reticuloendothelial system uptake which prolongs their in vivo circulation time. With the aim of developing dual therapy agent, 13-nm gold nanoparticles' (AuNPs) surfaces were coated with different amounts of polyethylene glycol (PEG) (SH-PEG-NH2) to obtain dense brush conformation-bearing theranostic agents. Among the 14 different theranostic agent candidates prepared, the one hosting 1819 PEG per particle was selected as the most promising theranostic agent candidate based on structural conformation, stability, size, zeta potential, hemocompatibility, cell inhibition, and cell death pathway towards MCF-7 cell line. To test drug delivery efficiency of the developed PEGylated AuNP and to improve efficacy of the treatment, apoptotic peptide (AP) was covalently conjugated to NH2 terminus of the PEG in various ratios to yield AuNP-AP conjugate. Among the prepared conjugates, the one having 1 nmol of peptide per milliliter of AuNP yielded the most promising results based on the same criteria as employed for PEGylated AuNPs. Besides, incorporation of AP to AuNP returned in superior efficacy of AP since it was possible to achieve 50% cell death with 1000 times less amount of AP alone.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Nanopartículas Metálicas / Nanomedicina Teranóstica / Ouro Limite: Humans Idioma: En Revista: Appl Biochem Biotechnol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Portadores de Fármacos / Nanopartículas Metálicas / Nanomedicina Teranóstica / Ouro Limite: Humans Idioma: En Revista: Appl Biochem Biotechnol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Turquia
...